Table 4.
Prevalence of high normal blood pressure and hypertension in parents participated in the second-stage screening
| I | II | III | IVParticipants as presented in column III, stratified by FINDRISC category | P-value* | |||
|---|---|---|---|---|---|---|---|
| Participants identified with high normal blood pressure, n (%) | Participants identified with hypertension, n (%) | Participants not receiving antihypertensive treatment among those identified with hypertension, n (%) | |||||
| 0–11 | 12–14 | 15–26 | |||||
| All countries (n = 2723) | 382 (14.0) | 507 (18.6) | 407 (80.3) | 231 (89.2)a,b | 116 (77.1)a,c | 60 (61.7)b,c | < 0.001 |
| HICs under austerity measures (n = 1261) | 154 (12.2) | 156 (12.4) | 121 (77.5) | 74 (88.8)a | 31 (73.2) | 16 (53.3)a | < 0.001 |
| LMICs (n = 582) | 74 (12.7) | 119 (20.5) | 84 (70.8) | 41 (79.6) | 29 (68.3) | 14 (56.5) | 0.121 |
| HICs (n = 880) | 154 (17.5) | 232 (26.4) | 202 (87.0) | 117 (93.3)a | 55 (85.5) | 30 (70.7)a | 0.001 |
*P-values indicate the significance of the differences among FINDRISC categories
Figures sharing the same superscript letters differentiate significantly from each other
FINDRISC Finnish Diabetes Risk Score, HICs High-income countries, LMICs Low to middle-income countries